Piramal (clinical research division) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Piramal (clinical research division) General Information

Description

Provider of generic drug trail services. The business provides the service for clinical trail for generic drugs. It also provides information about the trial of the generic drug in clinical tests.

Contact Information

Formerly Known As
Wellquest
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Hyderabad, Telangana
  • India
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Vertical(s)
TMT, HealthTech
Corporate Office
  • Hyderabad, Telangana
  • India

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Piramal (clinical research division) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Piramal (clinical research division)‘s full profile, request access.

Request a free trial

Piramal (clinical research division) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Piramal (clinical research division)‘s full profile, request access.

Request a free trial

Piramal (clinical research division) FAQs

  • Where is Piramal (clinical research division) headquartered?

    Piramal (clinical research division) is headquartered in Hyderabad, India.

  • What industry is Piramal (clinical research division) in?

    Piramal (clinical research division)’s primary industry is Laboratory Services (Healthcare).

  • Is Piramal (clinical research division) a private or public company?

    Piramal (clinical research division) is a Private company.

  • What is Piramal (clinical research division)’s current revenue?

    The current revenue for Piramal (clinical research division) is .

  • Who are Piramal (clinical research division)’s investors?

    Piramal Group has invested in Piramal (clinical research division).

  • When was Piramal (clinical research division) acquired?

    Piramal (clinical research division) was acquired on 06-Apr-2015.

  • Who acquired Piramal (clinical research division)?

    Piramal (clinical research division) was acquired by Indoco Remedies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »